Transferrin saturation (TSAT)

Editorial draft. The text has been read in full and copyedited. Clinical review and source verification are still pending.

What transferrin saturation (TSAT) actually measures

Iron saturation (transferrin saturation, TSAT) describes the share of transferrin’s binding sites that are occupied by iron. Many labs list 20–45 % as typical, below 20 % as low and above 45 % as high, although the ranges vary by method and laboratory. Transferrin is the main iron transport protein, and TSAT is calculated from two values in the same blood draw: serum iron divided by total iron-binding capacity (TIBC), multiplied by 100. Physiologically, it is a snapshot of supply and demand. Higher values show that more iron is available relative to transport capacity; lower values suggest that iron is scarce or functionally restricted.

Why TSAT shows what ferritin alone cannot

Transferrin binds iron and carries it through the blood. TSAT describes what share of its binding sites are occupied. Ferritin, by contrast, mainly reflects the body’s iron stores. The two values therefore answer different questions.

Serum iron on its own fluctuates from hour to hour depending on meals, supplements and time of day. TIBC reflects how much transport protein capacity is present. The ratio of the two captures the iron loading of the entire transport system, not just the serum iron concentration by itself. The distinction matters because the body regulates iron release through a hormone called hepcidin. When inflammation is present (signaled by cytokines such as IL-6), hepcidin rises and tells gut cells and storage sites to hold on to iron. Less iron enters the circulation, serum iron falls and TSAT falls, even when total body iron stores are adequate or high. Ferritin, meanwhile, rises with the same inflammatory signal, which creates the impression of adequate iron stores. TSAT can round out the interpretation: a low TSAT together with a high ferritin during illness points to functional iron restriction. The iron is there, but the transport system cannot get at it.

How iron saturation is calculated as a percentage

TSAT is derived from two values from the same blood draw: serum iron (the amount of iron circulating in plasma) and TIBC (total iron-binding capacity, which reflects how much transferrin protein is available). Divide iron by TIBC and multiply by 100, and you get the result as the percentage of transport capacity currently in use.

Transferrin saturation (TSAT): (serum iron [µg/dl] ÷ total iron-binding capacity [µg/dl]) × 100

The result is expressed as a percentage (%). Example: serum iron = 75 µg/dL, TIBC = 350 µg/dL → TSAT = (75 ÷ 350) × 100 = 21.4 %.

Some labs report transferrin directly (g/dl) instead of TIBC; an estimated TIBC can be derived from transferrin: TIBC ≈ transferrin (g/dl) × 70.9 µg/dl. The TSAT reported by the lab is calculated automatically when all three values are in the same panel.

Serum iron varies considerably with recent food intake, iron supplements and time of day: levels are highest in the morning and drop by as much as 30–50 % in the afternoon. For standardization, the source guide calls for a morning blood draw after 8–12 hours of fasting, a break from oral iron supplements of at least 24 hours, and a gap of at least 4 weeks after an intravenous iron infusion. These instructions need to be agreed with the medical practice. Acute illness can lower serum iron and TSAT via hepcidin; the value then describes the current inflammatory situation and not necessarily the person’s usual iron status.

A practical example: a 32-year-old woman with a serum iron of 48 µg/dL and a TIBC of 420 µg/dL has TSAT = (48 ÷ 420) × 100 = 11.4 %, well below the lower threshold of 20 % and consistent with iron deficiency. Her ferritin is also 8 ng/ml (stores depleted). The combination of low TSAT and low ferritin is the classic pattern of iron deficiency. By contrast, the same TSAT of 11 % alongside a ferritin of 180 ng/ml and an elevated hs-CRP (low TSAT despite high ferritin) points more toward functional iron restriction due to inflammation (hepcidin sequestration), where iron is present but not available to the transport system.

How are low and high values interpreted?

TSAT result	Possible interpretation	Possible further workup
Below 20 %	Iron deficiency or functional iron restriction due to inflammation	Ferritin and hs-CRP to tell the two apart
20–45 %	Typical range for most adults	Ferritin if fatigue, hair loss or poor physical recovery persist
Above 45 % with elevated ferritin	Possible iron overload	Testing for hemochromatosis and assessment of liver health according to clinical guidelines
Above 45 % in isolation	Reduced transferrin due to liver disease, or a temporary effect after recent intravenous iron	A repeat morning blood draw under agreed conditions to clarify the finding

Reference intervals come from large populations, not from individuals. Context (sex, life stage and inflammatory status) determines what a given number means.

Reliable interpretation requires comparable sampling conditions. Serum iron follows a daily rhythm: levels are highest in the morning and can drop considerably in the afternoon. Iron taken in with food or supplements raises serum iron acutely and pushes TSAT up for several hours. For follow-up testing, timing, fasting and the gap to iron supplements should be as comparable as possible and agreed with the medical practice.

Men and postmenopausal women tend to have a more stable iron balance; in people who menstruate, iron stores can run down more easily. Pregnancy naturally increases transferrin production, which can lower TSAT even as overall iron needs rise. Chronic inflammation lowers both transferrin and serum iron and shifts TSAT in ways that do not reflect the actual iron stores. TSAT is best interpreted together with ferritin, hemoglobin and an inflammatory marker.

What can change TSAT?

The main regulator of TSAT is hepcidin. Inflammatory signals, especially IL-6, drive hepcidin production, which blocks iron release from gut cells and macrophages via the transport protein ferroportin. The result is less iron entering the bloodstream, falling serum iron and a lower TSAT. This mechanism explains why TSAT can be low during an active infection or chronic inflammatory conditions, even when total body iron is normal or high. Oral contraceptives and pregnancy increase transferrin production, which can lower TSAT. Liver disease reduces transferrin synthesis, making TSAT appear higher than the underlying iron status justifies. Chronic kidney disease often leads to functional iron deficiency: TSAT is low despite adequate stores, especially when erythropoiesis-stimulating agents increase the bone marrow’s demand for iron.

Dietary iron intake: heme vs. non-heme, vitamin C and inhibitors

Food changes TSAT by changing both the amount of iron absorbed and the signals that control absorption. Heme iron from animal sources is absorbed efficiently; non-heme iron from plants is more variable. Vitamin C improves non-heme iron absorption by keeping it in a soluble form. Taking calcium or polyphenols (found in tea, coffee and many plant foods) at the same time is linked in research studies to reduced absorption of non-heme iron. Phytates in whole grains and legumes have a similar inhibiting effect; soaking, sprouting or fermenting these foods lowers their phytate content and improves bioavailability. Alcohol can increase iron absorption and, with chronic use, reduce transferrin production. Long-term use of proton pump inhibitors reduces stomach acid, which can limit non-heme iron absorption. After bariatric surgery, reduced acid secretion and altered gut anatomy often lower TSAT.

A hard training session can temporarily raise hepcidin for several hours, diverting iron into storage and lowering serum iron during that window. Foot strike and muscle stress can also increase iron turnover through mild hemolysis, especially in high-mileage runners. These are short-term effects; regular training may influence inflammation over the long term. The source guide describes possibly more favorable hepcidin rhythms and steadier iron availability; no reliable individual TSAT response can be inferred from this.

Medications, conditions and genetics

Testosterone therapy increases red blood cell production and can change iron availability. Adequate copper is needed to mobilize iron; copper deficiency can cause a low TSAT despite normal iron stores. HFE variants associated with hereditary hemochromatosis increase iron absorption over decades. Frequent blood donation and heavy menstrual bleeding produce the opposite pattern: a low TSAT that improves once iron losses decrease.

Which other blood tests help with interpretation?

Ferritin: reflects iron stores but also rises with inflammation; TSAT adds information on availability in the blood. A low TSAT with an elevated ferritin during illness points to functional iron restriction, without ferritin alone proving iron overload.
Serum iron (iron, total): the numerator of TSAT; serum iron and TSAT are looked at together to place iron availability and transport capacity in context.
Total iron-binding capacity (TIBC): the denominator of TSAT. It rises in iron deficiency (more transferrin available) and falls with inflammation or liver disease (less transferrin is produced). Combining TIBC with TSAT shows how much transport capacity is driving the ratio.
Hemoglobin: falls when restricted iron availability impairs red blood cell production. Combining TSAT with hemoglobin shows whether iron supply has started to affect red blood cell production.
hs-CRP: helps distinguish a low TSAT with low hs-CRP from a low TSAT with high hs-CRP and possible inflammation. It does not, however, reliably separate absolute from functional iron deficiency; both can be present at the same time.

When and under what conditions should you retest?

Serum iron varies considerably over the course of the day. For follow-up testing, comparable morning blood draws with an agreed gap to meals, iron supplements and exercise are helpful. Comparable sampling conditions matter as much as the interval between tests.

With oral iron repletion, TSAT typically responds within 4–8 weeks; ferritin takes longer, 8–12 weeks, to be replenished. A retest after 8–12 weeks captures both. During phlebotomy treatment for hemochromatosis, TSAT and ferritin should be checked every 2–4 weeks during the iron depletion phase and then every 3–6 months for maintenance, as directed by a physician. The source guide also mentions annual testing for healthy adults, or testing for fatigue, restless legs and hair loss. A general annual routine recommendation does not follow from this; what matters is the clinical question.

The source guide recommends waiting at least 24 hours after intense exercise before a blood draw: the post-exercise hepcidin peak leads to temporarily suppressed serum iron and a temporarily low TSAT that does not reflect baseline status. For all repeat tests, use the same lab, the same morning draw time, comparable fasting conditions and the same physician-agreed approach to pausing iron supplements (at least 24 hours in the source guide), so that changes in the number reflect changes in iron status rather than changes in conditions.

When should an abnormal value be looked into?

A single TSAT outside the range is a reason to check the sampling conditions and possible causes, not a diagnosis. Persistent patterns, confirmed by repeat morning blood draws under comparable conditions, warrant clinical follow-up.

A TSAT that is repeatedly below 20 % should be looked into in the context of the other values. Even before hemoglobin drops, a low TSAT correlates with reduced aerobic capacity and slower recovery, probably due to impaired mitochondrial function and altered activation of thyroid hormone.

A TSAT that stays above 45 % while ferritin rises also needs to be looked into. Persistent iron excess is associated over time with liver cirrhosis, cardiomyopathy and metabolic disorders.

In the following circumstances, TSAT must not be used as a measure of iron stores without additional context:

Acute illness: hepcidin rises and serum iron falls because of inflammation, regardless of actual iron status.
Within a few hours of an iron-rich meal or an oral iron supplement, serum iron rises acutely and TSAT is falsely elevated.
Within 2–4 weeks of an intravenous iron infusion, ferritin and TSAT remain elevated as a result of the infusion and do not reflect the underlying status.
Severe liver disease: transferrin production is low, so TSAT appears high because of a reduced denominator rather than true iron overload.

Over time, TSAT, ferritin, hemoglobin and, where relevant, hs-CRP complement one another. The physician’s assessment takes symptoms, conditions and sampling conditions into account. This does not automatically require the most extensive lab profile possible.

Frequently asked questions

What is iron saturation and what does it measure?

Iron saturation, also called transferrin saturation (TSAT), describes the share of occupied iron-binding sites on transferrin, the main iron transport protein in the blood. It is calculated as serum iron divided by total iron-binding capacity (TIBC), multiplied by 100. TSAT is a snapshot of how much of the iron transport capacity is actively in use, and it reflects the balance between iron availability and iron demand.

How is iron saturation measured and what affects accuracy?

TSAT is derived from two values measured in the same blood draw: serum iron and TIBC. Because serum iron is considerably higher after a meal, an iron supplement or an intravenous iron dose, results are most reliable when taken in the morning after an agreed fasting period and with enough time since any iron dose. Testing shortly after intense physical exercise or during an acute illness can also shift the values by changing hepcidin, the hormone that controls the release of iron into the bloodstream.

What is a normal iron saturation range?

Most labs give a reference range of about 20 to 45 %, although ranges vary by method and population. Fasting morning samples usually produce the most consistent results. Values below 20 % are generally considered low and may indicate iron deficiency or functional iron restriction. Values that stay above 45 %, especially with elevated ferritin, may prompt testing for iron overload. Reference ranges vary by laboratory and individual context.

What causes low iron saturation?

A low TSAT most often reflects iron deficiency due to blood loss, low dietary intake or increased needs such as pregnancy, rapid growth or heavy physical exercise. A low TSAT also occurs with inflammation, when the hormone hepcidin rises and locks iron in storage cells, so serum iron falls even when total body stores are adequate. Chronic kidney disease often leads to a functional iron deficit with low TSAT despite normal or high ferritin.

What are the symptoms of low iron saturation?

Before iron deficiency leads to anemia, a low TSAT can come with fatigue that worsens with exertion, slower recovery after exercise, difficulty concentrating, hair loss and restless legs. These symptoms can be subtle and overlap with many other conditions. Once hemoglobin falls, more classic anemia symptoms appear, including shortness of breath and cold intolerance. Symptoms should always be interpreted together with lab values, not in isolation.

What causes high iron saturation?

An elevated TSAT above 45 % may be due to a recent iron supplement or intravenous iron (a timing artifact), liver disease that reduces transferrin production (a higher ratio because fewer binding sites are available), or genetic iron overload syndromes such as hereditary hemochromatosis, in which the body absorbs more iron than it needs over decades. When TSAT is persistently elevated while ferritin rises, testing for iron overload with genetics and an assessment of liver health is usually recommended.

How often should I test my iron saturation?

For most people, TSAT is tested when symptoms suggest an iron imbalance, or as part of an anemia workup, rather than routinely. If you are supplementing iron or recovering from a deficiency, a retest after 8 to 12 weeks can help assess the response to treatment. For people monitoring hereditary hemochromatosis or managing conditions that affect iron metabolism, testing frequency is set by the treating physician.

Does endurance exercise affect iron saturation?

Yes. Intense endurance training, especially long-distance running, can lower TSAT through two mechanisms. First, physical exercise raises hepcidin for several hours, shifting iron into storage and lowering serum iron. Second, repeated foot strike causes a mild breakdown of red blood cells (intravascular hemolysis), which increases iron turnover and demand. These effects are temporary, but athletes with a heavy training load can show persistently lower TSAT if dietary iron intake does not keep pace with the increased demand.

Sources

Cacoub P, Vandewalle C, Peoc’h K (2019). Using transferrin saturation as a diagnostic criterion for iron deficiency: A systematic review. Critical reviews in clinical laboratory sciences, 56(8), 526-532. https://doi.org/10.1080/10408363.2019.1653820 Source
Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH (2007). Biological variability of transferrin saturation and unsaturated iron-binding capacity. The American journal of medicine, 120(11), 999.e1-7. https://doi.org/10.1016/j.amjmed.2007.02.027 Source
Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D (2005). Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood, 106(5), 1864-6. https://doi.org/10.1182/blood-2005-03-1159 Source
European Association for the Study of the Liver (2022). EASL Clinical Practice Guidelines on haemochromatosis. Journal of hepatology, 77(2), 479-502. https://doi.org/10.1016/j.jhep.2022.03.033 Source
Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS (2025). Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of clinical sleep medicine, 21(1), 137-152. https://doi.org/10.5664/jcsm.11390 Source